• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Admin

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

@rachel

Profile

Registered: 13 years ago


Forums

Topics Started: 2

Replies Created: 0

Forum Role: Keymaster

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Nov 20
7:45 am - 5:15 pm MST

Canadian Society of Palliative Medicine: Palliative Horizons – Clinical Approaches to ALS and Parkinson’s

Nov 24
9:00 am - 10:30 am EST

Annual General Meeting

Dec 5
December 5 - December 6

Alliance Meeting

Dec 7
December 7 - December 8

Allied Professionals Forum

View Calendar

  • Jean

    Jean
    jean

  • Jack Buzby, USA

    Jack Buzby, USA

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Susan Keldani, USA

    Susan Keldani, USA

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Phil Rossall, UK

    Phil Rossall, UK

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Michael Lee, Australia

    Michael Lee, Australia

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Rob Tison, USA

    Rob Tison, USA

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Andrew Langat, Kenya

    Andrew Langat, Kenya

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Zabun Nassar, England

    Zabun Nassar, England

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • John Dinon, Australia

    John Dinon, Australia

  • Art Eggert, USA

    Art Eggert, USA

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • David Solomon, UK

    David Solomon, UK

  • Bob Simonds, USA

    Bob Simonds, USA

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Bayley, Australia

    Bayley, Australia

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Ali Var, Turkey

    Ali Var, Turkey

  • Rosie Riley, USA

    Rosie Riley, USA

  • Mike Cels, Canada

    Mike Cels, Canada

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login